Searched for
INDRAPRASTHA MEDICAL SHARE TARGET
India must build export-oriented medical devices industry, says pharma secretaryTo bolster India's medical device industry, a strategic pivot toward international markets and enhanced global presence is essential. Foste...- India has 86,360 PG medical seats; no proposal to convert all diploma seats to DNB: GovtIndia now has over 86,000 postgraduate medical seats available nationwide. Karnataka leads the country with the highest number of these med...
- Indraprastha Medical Corporation shares surge 9% after Q1FY27 profit rises 9%, revenue grows 11%Indraprastha Medical Corporation shares surged over 8.5% to Rs 392.90 following strong Q1FY27 earnings. The healthcare operator reported a ...
- Hero MotoCorp shares jump 3% as Q1 profit rises 29% YoY, beats estimates. What's ahead?Hero MotoCorp shares jumped over 3% to Rs 5,739 following strong Q1 FY27 results. The two-wheeler giant reported a 29% YoY rise in standalo...
- Honeywell Aerospace shares plunge 26% as supply woes trigger forecast cutsHoneywell Aerospace shares dropped significantly after supply-chain problems impacted sales targets. The company lowered its annual sales g...
- Swiggy shares jump nearly 3% as company targets Rs 10,000 crore adjusted EBITDA by FY31Swiggy shares rose after the company unveiled an ambitious FY31 roadmap targeting Rs 10,000 crore in Adjusted EBITDA. It aims to more than ...
- F&O Radar: Call Ratio Spread strategy for Dixon this weekDixon Technologies demonstrates a robust bullish technical structure on the daily charts, trading above key EMAs with RSI at 63.27. Choice ...
- ICICI Bank, Bajaj Finance among Axis Securities’ top 8 largecap stock picks for AugustBenchmark indices witnessed broad-based gains, with leadership gradually shifting back towards largecap stocks. Here are the top eight larg...
- Buy, Sell or Hold: Nuvama maintains a buy on NYKAA and Uno Minda; Elara Securities recommends buy on Godrej PropertiesBrokerages remain bullish on select consumer, auto component, and real estate stocks. Nuvama reiterated 'Buy' on Nykaa (target Rs 414) and ...
- KEI Industries among 6 stocks showing bullish RSI upswingSix Nifty500 stocks, including KEI Industries, SAIL, and Delhivery, featured in the RSI Trending Up scan on 4 August after gaining over 2 p...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- Buy, Sell or Hold: Goldman Sachs maintains buy rating on Jindal Stainless; Citi recommends sell call on BioconIGI: Morgan Stanley stays bullish, citing strong certification-market growth and the company’s shift toward a consumer-focused business.Jin...
- Block deal alert: Meesho shares in focus as Peak XV, Elevation Capital eye Rs 1,900 crore stake salePeak XV and Elevation Capital plan to sell a 2.3 per cent stake in Meesho via Rs 1,900 crore block deals. This follows Meesho narrowing its...
- Comprehensive health insurance: Navigating childhood illnesses, vaccination support, and kidney function careHealth insurance covers childhood illnesses and their treatments effectively. Vaccination support is a key preventive care strategy for fam...
- Zinc India to remain at the driver seat for Vedanta, says ICICI Securities but cuts target price to Rs 345ICICI Securities cut Vedanta’s target price to Rs 345 from Rs 369, while retaining a positive view on zinc and silver prices. Zinc India re...
- ITC shares gain 3% after Q1 results. Here’s why Nomura upgraded the stock to BuyITC share Price: ITC shares rose 2% after the FMCG major reported June-quarter results, despite a 27% YoY decline in standalone net profit....
- Bajaj Finserv shares rise over 2% after Q1 earnings. Here's why Motilal Oswal upgrades to Buy, raises target priceBajaj Finserv shares climbed after reporting a 12% net profit increase for Q1 FY27. Revenue from operations grew nineteen percent year-on-y...
- Buy, Sell or Hold: Elara Capital downgrades Swiggy; Morgan Stanley remains overweight on M&MTop brokerages issued fresh stock views following mixed Q1 FY27 earnings. Elara Capital downgraded Swiggy to Accumulate with a target of Rs...
- BlueStone Jewellery shares soar 7%. Should you buy at current levels or avoid?BlueStone Jewellery and Lifestyle shares surged nearly 7%, extending their one-month rally to around 50% after robust Q1 FY27 earnings. The...
- Ambuja Cements share price target: Nuvama, Motilal, other brokerages see up to 30% upside. Here's whyAmbuja Cements shares rose over 1% despite reporting a 34% YoY decline in Q1 FY27 consolidated net profit to Rs 577 crore. Revenue fell 7.5...
Load More
